Lupus Research Alliance Grants Lupus Innovation Awards to Advance Ground-Breaking Lupus Research
NEW YORK, NY, March 23, 2023. The Lupus Research Alliance (LRA) today announced the recipients of the newest Lupus...
Search Results
You searched for: lupus nephritis
Results found: 1120
Lupus Research Alliance Announces 11 Exceptional Recipients of the 2021 Lupus Innovation Award
NEW YORK, NY, December 14, 2021. The Lupus Research Alliance proudly announced today recipients from the U.S. and around...
Lupus Research Alliance Grants Lupus Innovation Awards to Ten Talented Researchers to Accelerate Pace of Discovery in Lupus Research
The Lupus Research Alliance (LRA) is proud to announce the recipients of this year’s Lupus Innovation Award (LIA), addressing...
Scientists Focus on Innate Immune System as Possible Lupus Treatment Approach
January 7, 2019
The 2018 Forum for Discovery opened with a series of lectures on new research on the role of...
Positive One-Year Results of PALS Program Published in Prestigious Rheumatology Journal
The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced successful results of the Patient Advocates for...
Lupus Research Alliance and its Clinical Research Affiliate Lupus Therapeutics Launch the Lupus Landmark Study to Accelerate Personalized Treatments in Lupus
NEW YORK, NY. May 23, 2023 – The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics launched the...
LRA Joins NIAMS Coalition in Supporting Congressional Act Promoting Clinical Trial Diversity
The Lupus Research Alliance and Lupus Therapeutics support diversity in clinical trials to ensure that populations that test potential...
Bold Initiatives … Tremendous Strides Breaking Through on Lupus Research
In 2018 the Lupus Research Alliance has taken daring chances, pursued bold initiatives, and made tremendous strides! We truly...
Lupus Insight Prize Presented to Dr. Betty Diamond
The 2018 Lupus Insight Prize was awarded on June 21, 2018 to Betty Diamond, MD, Professor & Head, Center...
Join our 2026 Virtual Advocacy Day to Support Lupus Research
This year, together with advocates like you, we convinced Congress to restore millions in funding for lupus research. We...
Patient Involvement: Let Your Story Become Part of CommUnity
Patient Involvement: Let Your Story Become Part of CommUnity
The Lupus Research Alliance is pleased to invite you to join...
BLyS-specific Inhibitors
Belimumab, a type of agent referred to as a B-lymphocyte stimulator (BLyS) protein inhibitor, was approved by the U.S....